Applikon Biotechnology officially opens a new production facility in China

Event will be combined with a scientific seminar on bioreactor technology innovations

Applikon Biotechnology, a Netherlands-based developer of bioreactor systems from laboratory to production scale, will on 19 March officially open a new production facility in Guangzhou, China. The opening ceremony will be combined with a scientific seminar entitled: 'Innovations in bioreactor technology'.

The facility is located in a newly developed high tech science park in Guangzhou. The grand opening will be attended by customers, officials and a team from Applikon Biotechnology in the Netherlands.

The new production facility has been operational for several months and the festivities will celebrate this achievement.

Arthur Oudshoorn, Managing Director of Applikon Biotechnology, and his dedicated team say they are proud and happy with these new premises, which include offices, a warehouse, production facilities, QA/QC testing section and a technical support department.

The company can provide a complete range of bioreactor systems for pharmaceutical and biotechnological applications in the Chinese market from the new facility. Being closer to customers in China will decrease response time and improve the local technical support for users of advanced bioreactor systems, the company says.

Companies